Oak Hill takes SPAC track to Nasdaq with Roche asset in tow
Oak Hill takes SPAC track to Nasdaq with Roche asset in tow.
Oak Hill Bio
Private
Oak Hill Bio is a dermatology company. See today's news for the latest developments.
Company Info
Funding & Investor Relations
IPO Outlook / Plans
Nasdaq via SPAC (announced 2026-07-27)
Upcoming Milestones & Key Dates
2026-07-28
Milestone
Initial profile created
Clinical Development Pipeline
See pipeline
Target: See pipelineRecent News
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC.
Leadership Team
See company website
Leadership team